+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
All Ages
All Genders
ID03422198

Comparing Short Course and Standard Vaginal Cuff Brachytherapy for Early Stage Endometrial Cancer

Led by University of Utah · Updated on 2025-12-12

188

Participants Needed

5

Research Sites

152 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating short course vaginal cuff brachytherapy compared with the standard care of vaginal cuff brachytherapy in participants with stage I-II endometrial cancer. This phase III randomized trial aims to see how well the shorter treatment works and to assess its impact on patient quality of life and financial burden. The study was expanded after initial recruitment to include additional participants and monitor financial toxicity alongside quality of life outcomes. The trial compares two treatment groups one group receives short course vaginal cuff brachytherapy with 2 fractions spaced 1 week apart, while the other group receives the standard of care with 3 to 5 fractions over no more than 3 weeks. Both treatments involve placing radioactive material directly into or near the upper vagina to target cancer cells after surgery. Participants are closely monitored during and after treatment, with assessments of quality of life, treatment-related symptoms, diet, and activity levels. Financial toxicity and costs related to procedures are also evaluated. Outcome measures include changes in quality of life and patient-reported financial impact at one month post-treatment. The study continues until 2029, with ongoing recruitment and follow-up.

CONDITIONS

Brief Title

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

Research Team

R

Rachel Kingsford

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here